Amanote Research
Register
Sign In
The miRNA-184 Drives Renal Fibrosis by Targeting HIF1AN in Vitro and in Vivo
International Urology and Nephrology
- Netherlands
doi 10.1007/s11255-018-2025-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Urology
Nephrology
Date
December 10, 2018
Authors
Bin Chen
Publisher
Springer Science and Business Media LLC
Related search
3,3′-Diindolylmethane Ameliorates Renal Fibrosis Through the Inhibition of Renal Fibroblast Activation in Vivo and in Vitro
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
MiR-135-5p Promotes Osteoblast Differentiation by Targeting HIF1AN in Mc3t3-E1 Cells
Cellular and Molecular Biology Letters
Biochemistry
Cell Biology
Molecular Biology
Salvia Miltiorrhiza Ameliorates Liver Fibrosis by Activating Hepatic Natural Killer Cells in Vivo and in Vitro
Frontiers in Pharmacology
Pharmacology
LncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting miR-324-3p/DUSP1 Axis
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation in Vitro and in Vivo
Frontiers in Pharmacology
Pharmacology
Lipid Peroxidation Drives Renal Cyst Growth in Vitro Through Activation of TMEM16A
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
In Vivo Selective Inhibition of TRPC6 by Antagonist BI 749327 Ameliorates Fibrosis and Dysfunction in Cardiac and Renal Disease
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
microRNA-26a-5p Promotes Proliferation and Migration of Osteosarcoma Cells by Targeting HOXA5 in Vitro and in Vivo
OncoTargets and Therapy
Oncology
Pharmacology
Pirfenidone-Loaded Liposomes for Lung Targeting: Preparation and in Vitro/in Vivo Evaluation
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
